Abstract
Capability of nanofiltration membranes (NF) to remove pharmaceutical active compounds from wastewater streams was investigated. Sulfamethoxazole, diclofenac sodium, hydrochlorothiazide, 4-acetamidoantipyrine, nicotine and ranitinide hydrochloride were selected as model compounds since they are widely produced as pharmaceutical agents. Two commercially available polyamide nanofiltration membranes (NF-90 and NF-270 from Dow FilmTec) were tested. Solute retention by NF-90 membrane was very high in all cases (over 95%), whereas NF-270 retention systematically appeared lower ranging from 75% (nicotine) to 95% (ranitidine hydrochloride). Temporal evolution of flux decline was also investigated. The influence of physicochemical properties of both membrane and solutes on membrane performance was analyzed to explore the main solute-membrane interactions that determine the solute transfer across the membrane. The influence of operation pressure on NF-90 and NF-270 rejection was also studied. © 2012 Desalination Publications. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
López-Muñoz, M. J., Sotto, A., & Arsuaga, J. M. (2012). Nanofiltration removal of pharmaceutically active compounds. Desalination and Water Treatment, 42(1–3), 138–143. https://doi.org/10.5004/dwt.2012.2473
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.